A carregar...
Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma
BACKGROUND: Even though Hodgkin lymphoma is a highly curable disease, some of the patients have either a refractory disease or experience a relapse following a successful primary therapy. Durable responses and remissions in patients with relapsed or refractory disease may be achieved in approximatel...
Na minha lista:
| Publicado no: | Radiol Oncol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Versita, Warsaw
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722920/ https://ncbi.nlm.nih.gov/pubmed/26834516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0036 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|